Bibliografía del artículo
1. Martínez M, Sala J, Salvado J. Localización y utilidad clínica de las isoenzimas de la CK. Rev Diagn Biol 1981.
2. Kaldis P, Wallimann T. Functional differences between dimeric and octameric mitochondrial creatine kinase. Biochem J 308:623-627, 1995.
3. Clinical Diagnosis and Management by Laboratory Methods, Bernard Henry John 20th Edition, WB Saunders Compan,. 2001.
4. Mifflin TE, Bruns DE. University of Virginia. Case conference: macroamylase, macro creatine kinase and other macroenzynes. Clin Chem 31:1743-1748, 1986.
5. Galasso PJ, Litin SC, O'Brien JF. The macroenzymes: a clinical review. Mayo Clin Proc 68:349-354, 1993.
6. Maire I, Artur Y, Sanderink GI. Les macroenzymes dans le plasma humain. 1ª Partie. Macroamylase, macrocreatine kinase, macrolactate deshidrogenase. Ann Biol Clin 45:269-276, 1987.
7. Urdal P, Landaas S. Macro creatine kinase BB in serum, and some data on its prevalence. Clin Chem 25:461-5, 1979.
8. Stein W, Bohner J, Krais J, Muller M, Steinhart R, Eggstein M. Macro creatine kinase BB; evidence for specific binding between creatine kinase BB and immunoglobulin G. J Clin Chem Clin Biocem 19:925-30, 1981.
9. Venta R, Cecchini BG, Giejo SA, López-Ortín C, BAO CG, Cárdenas M et al. Serum creatine kinase MB after acute myocardial infarction in a patient with IgA-CK-BB complex. Clin Chem 40:160-161, 1994.
10. Urdal P. Macro creatine kinase BB isoenzyme in serum: most likely an antigen-autoantibody complex. Scand J Clin Lab Invest 41:499-505, 1981.
11. Pérez-Calle J, Marcos IM, Carneros J. Macrocreatincinasa tipo 1 en pacientes diagnosticados de colitis ulcerosa. Gastroenterol Hepatol 24:16-19, 2001.
12. Laureys M, Sion JP, Slabbynck H. Macromolecular creatin kinase type 1: a serum marker associated with disease. Clin Chem 37 (3):430-33, 1991.
13. Stein W, Bohner J, Bahlinger M. Analytical patterns and biochemical properties of macro creatine kinase type 2. Clin Chem 31:1952-1958, 1985.
14. Remaley AT, Wilding P. Macroenzymes: biochemical characterization, clinical significance, and laboratory detection. Clin Chem 35:2261-70, 1989.
15. Rosa Jiménez F, Gassó de Campos M, Camacho Reina MV, Arroyo Nieto A, Hernández Burruezo JJ. Macro-creatinquinasas: interés clínico. Rev Clin Esp 1:42-48, 1997.
16. Wu AH, Herson VC, Bowers GN. Macrocreatine kinase types 1 and 2; clinical significance in neonates and children as compared with adults. Clin Chem 29:201-204, 1983.
17. Fiehn W, Seiler D. Macrocreatine Kinase in plasma: A cuase for a false positive CK-MB immunoinhibition test. Klin Wochenschr 59:141-144, 1981.
18. Gadsden RH, Papadea CN, Cate JC. Analytical evaluation of methods for serum creatine kinase-MB. Ann Clin Lab Sci 24:110-120, 1994.
19. Ruelland A, Clerc C, Legras B, Cloarec L. Interference of macro-creatine kinase in determination of CK-MB in serum with the Kodak Ektachem. Clin Chem 325:2155-2156, 1989.
20. Galera R, Bardají A, Raga X, Vilanova A, Richart C. Macro CK tipo 2 como causa de falsa elevación de la CK-MB. Rev Esp Cardiol 45:350-351, 1992.
21. Saiz PA, Fernández AI. Enzimas séricas e infarto agudo de miocardio. Rev Diagn Biol 41:149-153, 1992.
22. Sociedad Española de Bioquímica Clínica y Patología Molecular. Comité Científico, Comisión de Interferencias y Efectos de los Medicamentos. Protocolo para el estudio de las interferencias por macroenzimas en la determinación de creatinacinasa 2. Quim Clin 18:156-9, 1999.
23. Ruelland A, Clerc C, Legras B, Cloarec L. Interference of macrocreatine kinase in determination of CK-MB in serum with the Kodak Ektachem. Clin Chem 35:2.155, 1989.
24. Murthy VV. Identification of false-positive CK-MB activity in a elderly patient. Am J Clin Pathol 99:97-100, 1993.
25. Gracia MC, Arrese R. Macro creatin kinasas. Rev Diagn Biol 39:47-50, 1990.
26. Martínez-Compadre GJ, Ortega B, Rueda M. ¿Puede un adenocarcinoma de próstata simular un infarto agudo de miocardio? Med Clin (Barc) 99:538-540, 1992.
27. Rowland LP, Willmer J, Cerri C, DiManro S, Miranda A. Approaches to the membrane theory of Duchenne muscular dystrophy. In Angelini C, Danieli GA, Fontanari D, editors. Muscular dystrophy-advances and new trends. Amsterdan, The Netherlands Excerpta Medica, pp. 3-13, 1980.
28. Ropper AH, Brown RH. Pruebas electrofisiológicas y auxiliares de laboratorio para el diagnóstico de las enfermedades neuromusculares. Principios de neurología, de Adams y Victor, 8ªEd., 45;1092-1109, 2007.
29. Sánchez MR, Peña M, Oliver C. Interferencia de la creatina quinasa BB en la determinación sérica de la CK-MB. Identificación de una macro-CK-1 en dos pacientes. Rev Diagn Biol 44:136-139, 1995.
30. Bassas E, Lombardo M, Galbarro J, Guerrero J, Perea R. Interferencia por macro CK tipo I en la determinación sérica de CK-MB A propósito de 2 casos. Rev Diagn Biol 44:40-41, 1995.
31. Laureys M, Sion JP, Slabbynck H, Steenssens L, Cobbeert C, Derde MP, et al. Macromolecular creatine kinase type 1: a serum marker associated with disease. Clin Chem 37:430-4, 1991.
32. Hattori N, Ikekubo K, Ishihara T, Moridera K, Hino M, Kurahachi H. A normal ovulatory woman with hyperprolactinemia: presence of anti-prolactin autoantibody and the regulation of prolactin secretion. Acta Endocrinol 126(6):497-500, 1992.
33. Bohner J, Stein W, et al. Stability of macro creatine kinases and creatine kinase isoenzymes compared: Heat inactivation test for determination of termostable creatine kinases. J Clin Chem Clin Biochem 19:1021-1026, 1981.
34. Kwong TC. Studies conducted at the University of Rochester Medical Center, Rochester, New York, 1986.
35. Wevers RA, Olthius HP, Van Niel JCC. A study on the dimeric structure of creatine kinase. Clin Chim Acta 75:377-385, 1977.
36. Clyne CA, Medeiros LJ, Martin KJ. The prognostic significance of immunoradiometric CK-MB assay (IRMA) diagnosis of myocardial infarction in patients with low total CK and elevated MB isoenzymes. Am Heart J 118:901-906, 1989.
37. Sturk A, Sanders GTB. Macroenzymes: prevalence, composition, detection and clinical relevance. J Clin Chem Clin Biochem 28:65-81, 1990.
38. Lee KN, Csako G, Bernhardt P, Elin RJ. Relevance of macro creatine kinase type 1 and type 2 isoenzymes to laboratory and clinical data. Clin Chem 40:1278-83, 1994.
39. Sánchez MR, Peña M, Oliver C. Interferencia de la creatin quinasa BB en la determinación sérica de CKMB. Identificación de una macro CK1 en dos pacientes. Rev Diag Biol 44:136-9, 1995.
40. Rosa-Jiménez F, Gassó de Campos M, Camacho MV, Vázquez E, Hernández JJ, Pousibet H. Macro creatine kinase type 1 as a cause of increase of CKMB isoenzyme. A propos of 7 cases. Rev Esp Cardiol 50:166-72, 1997.
41. Galasso PJ. Litin SC, O'Brien JF. The macroenzymes: a clinical review. Mayo Clinic Proc 68:349-354, 1993.
42. Schiferli JA, Despont JP, Cruchaud A, Carpenter N, Jeannet M, Schmidt M. Macro-creatine kinase type 1. Inmunological studies in 14 patients with comments on clinical significance. Arch Pathol Lab Med 110:425-429, 1986.
43. Tsung JS. Creatine kinase and its isoenzymes in neoplasic disease. Crit Rev Clin Lab Sci 23:65-75, 1986.
44. Lentjes EG, Backer ET. Increased serum lactate dehydrogenase isoenzyme 1 and macro creatine kinase type 2 in a patient with lung cancer. Clin Chim Acta 168:75-79, 1987.
45. Arenas J, Bornstein B, Mayor JA, Santos I, Leiva O, Martínez A. Macro creatine kinase type 2 in a patient with prostatic carcinoma. Clin Chim Acta 200:53-6, 1991.
46. Ruiz Ginés MA, Calafell Mas MF, Ruiz Ginés JA, Fernández Rodríguez E. Macro-creatincinasa: marcador de enfermedad. Guía práctica para su manejo. An Med Interna (Madrid) 23:272-275, 2006.
47. Rogalsky VY, Koven IH, Miller DR, Pollard A. Macrocreatine Kinase type 2 in the serum of patients with tumors and with non malignant colonic diseases. Cancer Detect Prev 8:477-483, 1985.
48. Koven IH, Freedman M, Miller D, et al. Macro-creatine Kinase 2: A possible marker of gastrointestinal cancer? Surgery 94:631-635, 1983.
49. Mercer DW, Talamo TS. Multiple markers of malignancy in sera of patients with colorectal carcinoma: preliminary clinical studies. Clin Chem 31:1824-1828, 1985.
50. Martínez Compadre GJ, Ortega B, Rueda M. ¿Puede un adenocarcinoma de próstata simular un infarto agudo de miocardio? Med Clin 99:538-40, 1992.
51. Wevers RA, Walters RJ, Soons JBJ. Isoelectric focusing and hybridization experiments on creatine kinase. Clin Chim Acta 78:271-276, 1977.